Baseline Clearance of Infliximab is Associated with Requirement for Colectomy in Patients with Acute Severe Ulcerative Colitis

BACKGROUND & AIMS: Hospitalized patients with acute severe ulcerative colitis (ASUC) often require surgery. Although the tumor necrosis factor antagonist infliximab is an effective salvage therapy to prevent colectomy in patients with ASUC, optimal dosing is unclear. Calculated infliximab cleara...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Gastroenterol Hepatol
Päätekijät: Battat, Robert, Hemperly, Amy, Truong, Stephanie, Whitmire, Natalie, Boland, Brigid S., Dulai, Parambir S, Holmer, Ariela K, Nguyen, Nghia H, Singh, Siddharth, Casteele, Niels Vande, Sandborn, William J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606215/
https://ncbi.nlm.nih.gov/pubmed/32348905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2020.03.072
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia